Biologics Market Scope And Analysis

  • Report Code : TIPRE00002765
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 200
Buy Now

Biologics Market Scope and Analysis by 2031

Buy Now


Biologics Market Report Scope

Report Attribute Details
Market size in 2023 US$ 469.2 Billion
Market Size by 2031 US$ 1,793.9 Billion
Global CAGR (2023 - 2031) 18.2%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Hormones/Proteins
  • Cell and Gene Therapies
By Application
  • Cancer
  • Infectious Diseases
  • Autoimmune Diseases
By Source
  • Mammalian
  • Microbial
By Manufacturing
  • Outsourced
  • In-House
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AbbVie Inc
  • Pfizer Inc
  • Samsung Biologics
  • ADMA Biologics Inc
  • WuXi Biologics
  • Catalent Inc
  • AGC Biologics
  • AstraZeneca
  • Amgen Inc
  • Avecia Biologics